Minerals Status in Relation to Overweight and Obese Adolescent
NCT ID: NCT06448858
Last Updated: 2024-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
84 participants
OBSERVATIONAL
2024-06-30
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relation Between Adiposity, Inflammation, Glycaemia and Iron Absorption
NCT03310203
Detection of Pre-Diabetes in Overweight and Obese Children
NCT06117358
The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD
NCT06449092
Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity
NCT06441409
The Effect of Calorie Deprivation on Adipose Tissue Distribution
NCT01658397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Micronutrients in obese people are explored because of an excess energy consumption, and therefore, an inadequate intake of trace elements and minerals. This imbalance among energy consumption and the intake is known as hidden hunger. Obesity can lead to nutritional metabolic disorders, in which the general state of trace elements and minerals are altered.
Only a few studies on child and adolescents obesity concerned Trace Elements (TE). TE is involved in the pathogenesis of obesity and obesity related diseases. We tried to assess trace elements status \[ Manganese (Mn), selenium (Se) copper (Cu),zinc (Zn)\] in obese children and their relationships with VAT and metabolic risk factors of obesity.
Manganese (Mn) is an essential trace element . It plays an important role in fat metabolism.
Selenium (Se) is an essential micronutrient that acts as an antioxidant and possesses multiple metabolic properties.
Copper (Cu) is a trace element that is vital. Cu has been reported to play a role in fat metabolism.
Zinc (Zn) plays an important role. Its deficiency impairs growth, metabolism and immunity.
Iron (Fe) is an essential trace element to sustain all forms of life. Existing research indicates iron deficiency is one of the comorbidities associated with obesity .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese
Patients with BMI more than 30
serum Mn, Se, iron, Cu & Zn levels
Evaluate the concentration of serum Mn, Se, iron, Cu \& Zn levels in obese and overweight adolescents.
Overweight
Patients with BMI 25-30
serum Mn, Se, iron, Cu & Zn levels
Evaluate the concentration of serum Mn, Se, iron, Cu \& Zn levels in obese and overweight adolescents.
Control
Patients with BMI less than 25
serum Mn, Se, iron, Cu & Zn levels
Evaluate the concentration of serum Mn, Se, iron, Cu \& Zn levels in obese and overweight adolescents.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
serum Mn, Se, iron, Cu & Zn levels
Evaluate the concentration of serum Mn, Se, iron, Cu \& Zn levels in obese and overweight adolescents.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with BMI over 25.
Exclusion Criteria
2. Patients with history of chronic use of mineral and /or vitamin supplements .
3. Patients with syndromal obesity , endocrine disorder and history of any chronic diseases ,
4. Patients under special diets or chronic use of medication .
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia Hussien Abdelmoneim Hassan
Resident doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university hospital
Asyut, Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Bluher M. Obesity: Global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 2019;15:288-298. doi: 10.1038/s41574-019-0176-8. \[PubMed\] \[CrossRef\] \[Google Scholar\]
Liu B., Du Y., Wu Y., Snetselaar L.G., Wallace R.B., Bao W. Trends in obesity and adiposity measures by race or ethnicity among adults in the United States 2011-18: Population based study. BMJ. 2021;372:n365. doi: 10.1136/bmj.n365. \[PMC free article\] \[
Li Y., Schoufour J., Wang D.D., Dhana K., Pan A., Liu X., Song M., Liu G., Shin H.J., Sun Q., et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: Prospective cohort study. BMJ. 2020;368:l6669. doi:
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Minerals in Adolescent
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.